COVID-19 Vaccine Moderna
The interim authorization for the COVID-19 Vaccine Moderna emergency therapeutic product by the Health Sciences Authority (HSA) of Singapore is made under Regulations 60A(4) and (5)(b) of the Health Product (Therapeutic Products) Regulations, for use and supply as directed by the Government of Singapore.
Patient Information Leaflet
Patient Information Leaflet
Summary of Product Characteristics
Summary of Product Characteristics
Storage, Handling, Dosage and Administration
Storage, Handling, Dosage and Administration
Contact Moderna
8am-5pm SST – Mon - Fri
APACmedinfo@modernatx.com